Headlines

As required by the Dignified Treatment of Wounded Warriors Act of 2008, the Physical Disability Board of Review (PDBR) allows veterans who were medically separated from service to have their disability rating reviewed.

Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®. The EMA reported 256 cases of serious and even fatal bleeding complications associated with Pradaxa.

Following Great Britain's phone-hacking scandal involving News of the World, numerous 9/11 families and survivors contacted the U.S. Justice Department to learn whether their phones and/or those of their deceased loved ones had been hacked following the 9/11 terrorist attacks.

On Dec. 15, 2011, the Environmental Protection Agency's (EPA) Inspector General signed a report to stop all unapproved asbestos removal methods employed by the EPA.

In an interview with Charleston reporter Carolyn Murray on the Comcast news program, Newsmakers, Motley Rice co-founder and asbestos lawyer Joe Rice discussed the success Motley Rice lawyers have had representing clients for nearly three decades.

The Federal Aviation Administration (FAA) implemented a set of regulations on Wednesday, Dec. 21, 2011, to prevent pilots from flying while dangerously fatigued.

Cameron International, a contractor for the Macondo well, has agreed to pay British Petroleum (BP) $250 million to settle liability disputes over the Deepwater Horizon well explosion.

The Environmental Protection Agency (EPA) has found asbestos contamination in the North Little Rock, Ark. community of Dixie, where a vermiculite-processing facility operated for nearly four decades. Officials believe the substance originated from a mine in Libby, Mont.

In the latest edition of <em>The Safety Report</em>, aviation lawyer Mary Schiavo wrote the article, "Holiday Travel Tips the Airline Won't Give You."

The US Food and Drug Administration (FDA) recently released the final report of an FDA-funded study regarding the risk of venous thromboembolism (VTE) in women taking hormonal contraceptives, finding that women who take drospirenone-containing birth-control pills are significantly more likely to develop a VTE than women using standard low-estrogen birth control pills.